Ann Arbor Stage IV Nodal Marginal Zone Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage IV Nodal Marginal Zone Lymphoma
| Record | Firm | Date |
|---|---|---|
| Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas (NCT03198026) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-02-20 |
Track Ann Arbor Stage IV Nodal Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.